Sequencing Kits and Accessories for Oxford Nanopore Sequencing Systems
ID: 75N95025Q00042Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAROCKVILLE, MD, 20852, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of sequencing kits and accessories for Oxford Nanopore Sequencing Systems. This acquisition aims to supply the Center for Alzheimer’s Disease and Related Dementias with essential sequencing kits for neurodegenerative disease research, aligning with the Global Parkinson’s Genetics Program to genotype over 150,000 volunteers globally. The anticipated award will be a firm fixed-price purchase order, with proposals due by 4:00 p.m. EST on December 18, 2024, and should be submitted electronically to Contracting Officer Eric McKay at eric.mckay@nih.gov. Interested parties must ensure compliance with federal regulations and provide detailed quotations, including product specifications and pricing.

    Point(s) of Contact
    Files
    Title
    Posted
    The purpose of this acquisition is to supply the Center for Alzheimer’s Disease and Related Dementias with sequencing kits for neurodegenerative disease research, specifically for long read sequencing on Oxford Nanopore systems. This initiative aligns with the Global Parkinson’s Genetics Program (GP2), which aims to genotype over 150,000 volunteers globally to explore the genetic factors of Parkinson’s disease. The required supplies include PromethION Flow Cells, Ligation Sequencing Kits, Flow Cell Wash Kits, and Sequencing Auxiliary Vials, with specified quantities and delivery dates ranging from 2025 to 2027. Key characteristics of the flow cells include the capacity to generate up to 290 Gb of sequencing data and compatibility with Nanopore PromethION 48 sequencers. All deliverables must adhere to government specifications for packaging and shipping. The acquisition includes a base period and two optional extension periods.
    The document outlines the "Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment" as mandated by federal regulations. It emphasizes that Offerors do not need to complete specific representations if they previously affirmed they do not provide or use covered telecommunications equipment or services. Notably, this provision stems from Section 889 of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, prohibiting agencies from procuring certain telecommunications services and equipment that may pose security risks. It includes definitions of key terms and details the prohibitions tied to the use of covered telecommunications. The Offeror is required to conduct a reasonable inquiry and accurately disclose their status concerning covered services and equipment. Additional disclosure is mandated if the Offeror indicates the presence of such equipment or services, requiring them to provide specific details about the equipment or services involved, and to explain how their use complies with the prohibitions. Overall, the provision emphasizes compliance and transparency in federal procurements regarding telecommunications services.
    The provision 52.204-26 on "Covered Telecommunications Equipment or Services-Representation" outlines requirements for offerors regarding the use of certain telecommunications equipment or services in federal contracts. It emphasizes the need to review the System for Award Management (SAM) for entities excluded from receiving federal awards due to these provisions. The offeror must declare whether it provides or uses covered telecommunications equipment or services after conducting a reasonable inquiry. This requirement is aimed at ensuring compliance with federal regulations prohibiting specific telecommunications and surveillance services. The document highlights the importance of transparency and accountability in government contracting, particularly concerning national security risks associated with particular telecommunications technologies.
    The document provides an overview of the Federal Acquisition Regulation (FAR) clause 52.212-5, which outlines the contractual terms and conditions mandated to execute laws or executive orders relevant to acquiring commercial products and services. It stipulates compliance requirements for contractors, detailing applicable FAR clauses that cover ethics, whistleblower protections, small business considerations, and labor standards. Key points include restrictions on subcontractor sales, reporting executive compensation, equal opportunity mandates, and compliance with regulations addressing prohibited foreign entities. The clause also mandates maintaining records for auditing purposes and specifies which provisions must flow down to subcontractors. Overall, the purpose of the document is to ensure contractors are aware of their obligations under federal law, particularly in the context of government RFPs and grants. The extensive list of clauses emphasizes the federal government's commitment to ethical conduct, support for small businesses, and the importance of compliance with labor laws and security measures. This strengthen oversight on government contracts while fostering fair competition and accountability in federal procurement processes.
    The Trade Agreements Certificate, as outlined in provision 52.225-6, certifies that the offeror's products are primarily U.S.-made or from designated countries, in compliance with trade agreements. The offeror must explicitly list any products not meeting this criterion as "other end products," providing details such as line item numbers and countries of origin where necessary. The government evaluates offers based on Federal Acquisition Regulation (FAR) guidelines, allowing for U.S.-made or designated country products' preference over those restricted by the Buy American statute, unless there are no viable offers. This provision underscores the government's intent to promote domestic manufacturing while allowing flexibility under international trade agreements. The document is essential for management of federal contracts, ensuring compliance with trade policies and procurement procedures.
    The document outlines the Invoice and Payment Provisions relevant to federal contracts, specifically detailing requirements for invoicing and payment under Purchase Orders and Blanket Purchase Agreements. It emphasizes strict compliance with outlined invoice requirements, including necessary details such as Contractor information, unique identifiers, and a description of services rendered. Invoices must be submitted via the Department of Treasury’s Invoice Processing Platform (IPP), ensuring electronic processing. Payment deadlines are stipulated, typically occurring within 30 days of receiving a correct invoice or acceptance of delivered goods/services. Special provisions are made for perishable goods, following the Prompt Payment Act. Interest penalties will apply for late payments if proper conditions are met. The document also includes a clause for expedited payments to small business subcontractors, mandating that these payments are processed swiftly without additional charges. All invoicing procedures must comply with the specified government regulations, ensuring accountability and efficiency in financial interactions with contractors. This guidance serves to enhance the adherence to federal finance protocols in procurement processes.
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Q--Jackson Heart Study Whole Genome Sequencing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the Jackson Heart Study Whole Genome Sequencing project. This initiative aims to conduct comprehensive whole genome sequencing to enhance understanding of cardiovascular health within the Jackson Heart Study cohort. The services procured will play a crucial role in advancing medical research and improving health outcomes related to heart disease. Interested parties can reach out to Helmut Winffel at helmut.winffel@nih.gov or call 301-435-0330 for further details regarding the presolicitation notice.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Preventative Maintenance and Service Package for the Mediso nanoScan PET/CT animal imager
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking qualified vendors to provide a Preventative Maintenance and Service Package for the Mediso NanoScan PET/CT animal imager. This procurement involves a comprehensive service plan that includes a 12-month base period followed by four optional 12-month periods, commencing on February 10, 2025, at the Biomedical Research Center in Baltimore, Maryland. The Mediso NanoScan PET/CT is crucial for advanced imaging in biomedical research, and the selected vendor must demonstrate technical capabilities, customer support, and delivery speed as part of the evaluation process. Interested parties should note that the Request for Quotation (RFQ) number is 75N95025Q00104, with responses due by January 6, 2025. For further inquiries, vendors can contact Andrew Varley at andrew.varley@nih.gov or Joshua T. Lazarus at Josh.Lazarus@nih.gov.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) to support gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract aims to provide essential resources and services, including administrative management, core laboratory activities, and compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is crucial for advancing gene therapy capabilities and ensuring the proper archiving of biological specimens and development of assays. Proposals must be submitted by January 10, 2025, and should include detailed technical and business plans, with specific formatting guidelines and a budget submission required. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153.
    iThenticate Plagiarism Detection Software License (or equal)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a software license for iThenticate, a plagiarism detection tool essential for the Intramural Research Program's manuscript preparations. The software must provide capabilities to check for plagiarism, assess manuscript originality, and identify AI-generated content, aligning with modern academic integrity standards. This acquisition is crucial for maintaining research integrity and improving the quality of scholarly outputs within government-funded research initiatives. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on January 10, 2025, referencing Solicitation Number 75N95025Q00070-RFQ, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547.
    A--Biomedical Computing Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for Biomedical Computing Support Services to assist in ongoing cancer research initiatives. The procurement aims to provide comprehensive computing services that facilitate the analysis of high-dimensional biomedical data, supporting both domestic and international studies within the Division of Cancer Epidemiology and Genetics (DCEG). This opportunity is critical for enhancing cancer research capabilities, with an estimated contract value ranging from $3,000 to $147 million over a performance period of five years, beginning September 16, 2025, with a potential five-year extension. Interested offerors must submit their proposals by January 6, 2025, and can direct inquiries to Antoinette C. Robinson at antoinette.robinson@nih.gov or by phone at +1 240 276 5823.